XML 142 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Financial Assets and Liabilities
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Financial Assets and Liabilities
 
Financial Instruments Measured at Fair Value
 
The fair value of equities, options, on-the-run U.S. government obligations and exchange traded notes is estimated using recently executed transactions and market price quotations in active markets and are categorized as Level 1 with the exception of inactively traded equities and certain other financial instruments, which are categorized as Level 2. The Company’s corporate bonds, derivative contracts and other U.S. and non-U.S. government obligations have been categorized as Level 2. Fair value of the Company’s derivative contracts is based on the indicative prices obtained from a number of banks and broker-dealers, as well as management’s own analyses. The indicative prices have been independently validated through the Company’s risk management systems, which are designed to check prices with information independently obtained from exchanges and venues where such financial instruments are listed or to compare prices of similar instruments with similar maturities for listed financial futures in foreign exchange.
 
The Company prices certain financial instruments held for trading at fair value based on theoretical prices, which can differ from quoted market prices. The theoretical prices reflect price adjustments primarily caused by the fact that the Company continuously prices its financial instruments based on all available information. This information includes prices for identical and near-identical positions, as well as the prices for securities underlying the Company’s positions, on other exchanges that are open after the exchange on which the financial instruments is traded closes. The Company validates that all price adjustments can be substantiated with market inputs and checks the theoretical prices independently. Consequently, such financial instruments are classified as Level 2.

There were no transfers of financial instruments between levels during the years ended December 31, 2019, 2018 and 2017.
 
Fair value measurements for those items measured on a recurring basis are summarized below as of December 31, 2019:
 
 
December 31, 2019
(in thousands)
 
Quoted Prices in Active Markets for Identical Assets (Level 1) 
 
Significant Other Observable Inputs (Level 2) 
 
Significant Unobservable Inputs (Level 3) 
 
Counterparty and Cash Collateral Netting 
 
Total Fair Value 
Assets
 
 
 
 
 
 
 
 
 
 
Financial instruments owned, at fair value:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
$
600,259

 
$
1,080,518

 
$

 
$

 
$
1,680,777

U.S. and Non-U.S. government obligations
 
106,690

 
20,847

 

 

 
127,537

Corporate Bonds
 

 
171,591

 

 

 
171,591

Exchange traded notes
 
243

 
48,894

 

 

 
49,137

Currency forwards
 

 
242,552

 

 
(211,398
)
 
31,154

Options
 
8,538

 

 

 

 
8,538

 
 
715,730

 
1,564,402

 

 
(211,398
)
 
2,068,734

 
 
 
 
 
 
 
 
 
 
 
Financial instruments owned, pledged as collateral:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
362,439

 
291,927

 

 

 
654,366

Exchange traded notes
 
12

 
42,578

 

 

 
42,590

 
 
362,451

 
334,505

 

 

 
696,956

 
 
 
 
 
 
 
 
 
 
 
Other Assets
 
 
 
 
 
 
 
 
 
 
Equity investment
 

 

 
46,245

 

 
46,245

Exchange stock
 
2,721

 

 

 

 
2,721

 
 
2,721

 

 
46,245

 

 
48,966

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
Financial instruments sold, not yet purchased, at fair value:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
1,022,814

 
1,163,888

 

 

 
2,186,702

U.S. and Non-U.S. government obligations
 
39,091

 
2,713

 

 

 
41,804

Corporate Bonds
 

 
244,700

 

 

 
244,700

Exchange traded notes
 
15

 
21,631

 

 

 
21,646

Currency forwards
 

 
196,554

 

 
(196,535
)
 
19

Options
 
3,087

 

 

 

 
3,087

 
 
$
1,065,007

 
$
1,629,486

 
$

 
$
(196,535
)
 
$
2,497,958


Fair value measurements for those items measured on a recurring basis are summarized below as of December 31, 2018:
 
 
December 31, 2018
(in thousands)
 
Quoted Prices in Active Markets for Identical Assets (Level 1) 
 
Significant Other Observable Inputs (Level 2) 
 
Significant Unobservable Inputs (Level 3) 
 
Counterparty and Cash Collateral Netting 
 
Total Fair Value 
Assets
 
 
 
 
 
 
 
 
 
 
Financial instruments owned, at fair value:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
$
587,680

 
$
1,022,221

 
$

 
$

 
$
1,609,901

U.S. and Non-U.S. government obligations
 
91,466

 
14,547

 

 

 
106,013

Corporate Bonds
 

 
87,500

 

 

 
87,500

Exchange traded notes
 
3,396

 
27,966

 

 

 
31,362

Currency forwards
 

 
2,792,373

 

 
(2,790,242
)
 
2,131

Options
 
11,899

 

 

 

 
11,899

 
 
694,441

 
3,944,607

 

 
(2,790,242
)
 
1,848,806

Financial instruments owned, pledged as collateral:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
389,810

 
359,036

 

 

 
748,846

U.S. and Non-U.S. government obligations
 

 

 

 

 

Exchange traded notes
 
6,968

 
35,301

 

 

 
42,269

 
 
396,778

 
394,337

 

 

 
791,115

Other Assets
 
 
 
 
 
 
 
 
 
 
Equity investment
 

 

 
45,856

 

 
45,856

Exchange stock
 
2,417

 

 

 

 
2,417

 
 
2,417

 

 
45,856

 

 
48,273

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
Financial instruments sold, not yet purchased, at fair value:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
931,992

 
1,336,338

 

 

 
2,268,330

U.S. and Non-U.S. government obligations
 
112,058

 
3,054

 

 

 
115,112

Corporate Bonds
 

 
40,123

 

 

 
40,123

Exchange traded notes
 
371

 
39,613

 

 

 
39,984

Currency forwards
 

 
2,720,749

 

 
(2,719,954
)
 
795

Options
 
11,051

 

 

 

 
11,051

 
 
$
1,055,472

 
$
4,139,877

 
$

 
$
(2,719,954
)
 
$
2,475,395



SBI Investment

The Company has a minority investment (the “SBI Investment”) in SBI Japannext Co., Ltd. (“SBI”), a proprietary trading system based in Tokyo. In connection with the SBI Investment, the Company issued the SBI Bonds (as described in Note 10 “Borrowings”) and used the proceeds to partially finance the transaction. As of December 31, 2019, the fair value of the SBI Investment was determined using the discounted cash flow method, an income approach, with the discount rate of 15.0% applied to the cash flow forecasts. The Company also used a market approach based on 12.6x average price/earnings multiples of comparable companies to corroborate the income approach. The fair value of the SBI Investment at December 31, 2019 was determined by taking the weighted average of enterprise valuations based on discounted cash flow on projected income from the next five years, the implied enterprise valuations on comparable companies, and the implied enterprise valuations on comparable transactions. The fair value measurement is highly sensitive to significant changes in the unobservable inputs and significant increases (decreases) in discount rate or decreases (increases) in price/earnings multiples would result in a significantly lower (higher) fair value measurement. Changes in the fair value of the SBI Investment are reflected in Other, net in the Consolidated Statements of Comprehensive Income.

Financial Instruments Not Measured at Fair Value
 
The table below presents the carrying value, fair value and fair value hierarchy category of certain financial instruments that are not measured at fair value on the Consolidated Statement of Financial Condition. The table below excludes non-financial assets and liabilities. The carrying value of financial instruments not measured at fair value categorized in the fair value hierarchy as Level 1 and Level 2 approximates fair value due to the relatively short-term nature of the underlying assets. The fair value of the Company’s long-term borrowings is based on quoted prices from the market for similar instruments, and is categorized as Level 2 in the fair value hierarchy.

The table below summarizes financial assets and liabilities not carried at fair value on a recurring basis as of December 31, 2019:
 
 
December 31, 2019
 
 
 

 
 

 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
 (in thousands)
 
Carrying Value
 
Fair Value
 
(Level 1) 
 
(Level 2) 
 
(Level 3) 
Assets
 
 

 
 

 
 

 
 

 
 

Cash and cash equivalents
 
$
732,164

 
$
732,164

 
$
732,164

 
$

 
$

Cash restricted or segregated under regulations and other
 
41,116

 
41,116

 
41,116

 

 

Securities borrowed
 
1,928,763

 
1,928,763

 

 
1,928,763

 

Securities purchased under agreements to resell
 
143,032

 
143,032

 

 
143,032

 

Receivables from broker-dealers and clearing organizations
 
1,318,584

 
1,318,584

 
40,842

 
1,277,742

 

Total Assets
 
4,163,659

 
4,163,659

 
814,122

 
3,349,537

 

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
Short-term borrowings
 
73,486

 
75,586

 

 
75,586

 

Long-term borrowings
 
1,917,866

 
1,966,850

 

 
1,966,850

 

Securities loaned
 
1,600,099

 
1,600,099

 

 
1,600,099

 

Securities sold under agreements to repurchase
 
340,742

 
340,742

 

 
340,742

 

Payables to broker-dealers and clearing organizations
 
826,750

 
826,750

 
49,514

 
777,236

 

Total Liabilities
 
$
4,758,943

 
$
4,810,027

 
$
49,514

 
$
4,760,513

 
$

 
The table below summarizes financial assets and liabilities not carried at fair value on a recurring basis as of December 31, 2018:
 
 
December 31, 2018
 
 
 

 
 

 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
 (in thousands)
 
Carrying Value
 
Fair Value
 
(Level 1) 
 
(Level 2) 
 
(Level 3) 
Assets
 
 

 
 

 
 

 
 

 
 

Cash and cash equivalents
 
$
736,047

 
$
736,047

 
$
736,047

 
$

 
$

Securities borrowed
 
1,399,684

 
1,399,684

 

 
1,399,684

 

Securities purchased under agreements to resell
 
15,475

 
15,475

 

 
15,475

 

Receivables from broker-dealers and clearing organizations
 
1,101,449

 
1,101,449

 
71,288

 
1,030,161

 

Total Assets
 
3,252,655

 
3,252,655

 
807,335

 
2,445,320

 

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
Short-term borrowings
 
15,128

 
15,128

 

 
15,128

 

Long-term borrowings
 
907,037

 
916,465

 

 
916,465

 

Securities loaned
 
1,130,039

 
1,130,039

 

 
1,130,039

 

Securities sold under agreements to repurchase
 
281,861


281,861




281,861



Payables to broker dealer and clearing organizations
 
567,441

 
567,441

 
1,031

 
566,410

 

Total Liabilities
 
$
2,901,506

 
$
2,910,934

 
$
1,031

 
$
2,909,903

 
$



The following presents the changes in Level 3 financial instruments measured at fair value on a recurring basis:

 
 
Year Ended December 31, 2019
(in thousands)
 
Balance at December 31, 2018
 
Purchases
 
Total Realized and Unrealized Gains / (Losses)
 
Net Transfers into (out of) Level 3
 
Settlement
 
Balance at December 31, 2019
 
Change in Net Unrealized Gains / (Losses) on Investments still held at December 31, 2019
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity investment
 
$
45,856

 
$

 
$
389

 
$

 
$

 
$
46,245

 
$
389

Total
 
45,856

 

 
389

 

 

 
46,245

 
389


 
 
Year Ended December 31, 2018
(in thousands)
 
Balance at December 31, 2017
 
Purchases
 
Total Realized and Unrealized Gains / (Losses)
 
Net Transfers into (out of) Level 3
 
Settlement
 
Balance at December 31, 2018
 
Change in Net Unrealized Gains / (Losses) on Investments still held at December 31, 2018
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity investment
 
$
40,588

 
$

 
$
5,268

 
$

 
$

 
$
45,856

 
$
5,268

Total
 
40,588

 

 
5,268

 

 

 
45,856

 
5,268


 
Offsetting of Financial Assets and Liabilities
 
The Company does not net securities borrowed and securities loaned, or securities purchased under agreements to resell and securities sold under agreements to repurchase. These financial instruments are presented on a gross basis in the Consolidated Statements of Financial Condition. In the tables below, the amounts of financial instruments owned that are not offset in the Consolidated Statements of Financial Condition, but could be netted against financial liabilities with specific counterparties under legally enforceable master netting agreements in the event of default, are presented to provide financial statement readers with the Company’s estimate of its net exposure to counterparties for these financial instruments.

The following tables set forth the gross and net presentation of certain financial assets and financial liabilities as of December 31, 2019 and December 31, 2018:
 
 
December 31, 2019
 
 
Gross Amounts of Recognized Assets
 
 Amounts Offset in the Consolidated Statement of Financial Condition
 
 Amounts of Assets Presented in the Consolidated Statement of Financial Condition
 
 
 
 
 
 
 
 
 
 Amounts Not Offset in the Consolidated Statement of Financial Condition
 
 
(in thousands)
 
 
 
 
Financial Instruments
 
Cash Collateral Received
 
Net Amount
Offsetting of Financial Assets:
 
    
 
    
 
    
 
    
 
    
 
    
Securities borrowed
 
$
1,928,763

 
$

 
$
1,928,763

 
$
(1,881,005
)
 
$
(15,280
)
 
$
32,478

Securities purchased under agreements to resell
 
143,032

 

 
143,032

 
(142,922
)
 

 
110

Trading assets, at fair value:
 
 
 
 
 
 
 
 
 
 
 
 
Currency forwards
 
242,552

 
(211,398
)
 
31,154

 

 

 
31,154

Options
 
8,538

 

 
8,538

 
(8,537
)
 

 
1

Total
 
$
2,322,885

 
$
(211,398
)
 
$
2,111,487

 
$
(2,032,464
)
 
$
(15,280
)
 
$
63,743

 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Consolidated Statement of Financial Condition
 
Net Amounts of Liabilities Presented in the Consolidated Statement of Financial Condition
 
 
 
 
 
 
 
 
 
 Amounts Not Offset in the Consolidated Statement of Financial Condition
 
 
(in thousands)
 
 
 
 
Financial Instruments 
 
Cash Collateral Pledged 
 
Net Amount 
Offsetting of Financial Liabilities:
 
    
 
 
 
    
 
    
 
    
 
    
Securities loaned
 
$
1,600,099

 
$

 
$
1,600,099

 
$
(1,552,146
)
 
$
(15,281
)
 
$
32,672

Securities sold under agreements to repurchase
 
340,742

 

 
340,742

 
(340,718
)
 

 
24

Trading liabilities, at fair value:
 
 
 
 
 
 
 
 
 
 
 
 
Currency forwards
 
196,554

 
(196,535
)
 
19

 

 

 
19

Options
 
3,087

 

 
3,087

 
(3,087
)
 

 

Total
 
$
2,140,482

 
$
(196,535
)
 
$
1,943,947

 
$
(1,895,951
)
 
$
(15,281
)
 
$
32,715

 
 
 
December 31, 2018
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Consolidated Statement of Financial Condition
 
Net Amounts of Assets Presented in the Consolidated Statement of Financial Condition
 
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Consolidated Statement of Financial Condition
 
 
(in thousands)
 
 
 
 
Financial Instruments 
 
Cash Collateral Received 
 
Net Amount 
Offsetting of Financial Assets:
 
    
 
    
 
    
 
    
 
    
 
    
Securities borrowed
 
$
1,399,684

 
$

 
$
1,399,684

 
$
(1,361,635
)
 
$
(8,822
)
 
$
29,227

Securities purchased under agreements to resell
 
15,475

 

 
15,475

 
(15,475
)
 

 

Trading assets, at fair value:
 
 
 
 
 
 
 
 
 
 
 
 
Currency forwards
 
2,792,373

 
(2,790,242
)
 
2,131

 

 

 
2,131

Options
 
11,899

 

 
11,899

 
(11,899
)
 

 

Total
 
$
4,219,431

 
$
(2,790,242
)
 
$
1,429,189

 
$
(1,389,009
)
 
$
(8,822
)
 
$
31,358

 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Consolidated Statement of Financial Condition
 
Net Amounts of Liabilities Presented in the Consolidated Statement of Financial Condition
 
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Consolidated Statement of Financial Condition 
 
 
(in thousands)
 
 
 
 
Financial Instruments 
 
Cash Collateral Pledged 
 
Net Amount 
Offsetting of Financial Liabilities:
 
    
 
 
 
    
 
    
 
    
 
    
Securities loaned
 
$
1,130,039

 
$

 
$
1,130,039

 
$
(1,108,461
)
 
$
(8,822
)
 
$
12,756

Securities sold under agreements to repurchase
 
281,861

 

 
281,861

 
(281,861
)
 

 

Trading liabilities, at fair value:
 
 
 
 
 
 
 
 
 
 
 
 
Currency forwards
 
2,720,749

 
(2,719,954
)
 
795

 

 
(792
)
 
3

Options
 
11,051

 

 
11,051

 
(11,051
)
 

 

Total
 
$
4,143,700

 
$
(2,719,954
)
 
$
1,423,746

 
$
(1,401,373
)
 
$
(9,614
)
 
$
12,759


 
The following table presents gross obligations for securities sold under agreements to repurchase and for securities lending transactions by remaining contractual maturity and the class of collateral pledged:
 
 
December 31, 2019
 
 
Remaining Contractual Maturity
(in thousands)
 
Overnight and Continuous
 
Less than 30 days
 
30 - 60
days
 
61 - 90
Days
 
Total
 
 
 
 
 
 
 
 
 
 
 
Securities sold under agreements to repurchase:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
$

 
$
75,000

 
$
50,000

 
$
150,000

 
$
275,000

U.S. and Non-U.S. government obligations
 
65,742

 

 

 

 
65,742

Total
 
65,742

 
75,000

 
50,000

 
150,000

 
340,742

 
 
 
 
 
 
 
 
 
 
 
Securities loaned:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
1,600,099

 

 

 

 
1,600,099

Total
 
$
1,600,099

 
$

 
$

 
$

 
$
1,600,099

 
 
December 31, 2018
 
 
Remaining Contractual Maturity
(in thousands)
 
Overnight and Continuous
 
Less than 30 days
 
30 - 60
days
 
61 - 90
Days
 
Total
 
 
 
 
 
 
 
 
 
 
 
Securities sold under agreements to repurchase:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
$

 
$
45,000

 
$
65,000

 
$
160,000

 
$
270,000

U.S. and Non-U.S. government obligations
 
11,861

 

 

 

 
11,861

Total
 
11,861

 
45,000

 
65,000

 
160,000

 
281,861

 
 
 
 
 
 
 
 
 
 
 
Securities loaned:
 
 
 
 
 
 
 
 
 
 
Equity securities
 
1,130,039

 

 

 

 
1,130,039

Total
 
$
1,130,039

 
$

 
$

 
$

 
$
1,130,039